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Abstract
Background
The dietary management of methylmalonic acidaemia (MMA) is a low-protein diet providing
sufficient energy to avoid catabolism and to limit production of methylmalonic acid. The goal is to
achieve normal growth, good nutritional status and the maintenance of metabolic stability.
Aim
To describe the dietary management of patients with MMA across Europe.
Methods
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A cross-sectional questionnaire was sent to European colleagues managing inherited metabolic
disorders (IMDs) (n=53) with 27 questions about the nutritional management of organic
acidaemias. Data were analysed by different age ranges (0–6 months; 7–12 months; 1–10 years;
11–16 years; >16 years).
Results
Questionnaires were returned from 53 centres. Twenty-five centres cared for 80 patients with
MMA vitamin B12 responsive (MMAB12r) and 43 centres managed 215 patients with MMA
vitamin B12 non-responsive (MMAB12nr). For MMAB12r patients, 44% of centres (n=11/25)
prescribed natural protein below the World Health Organization/Food and Agriculture
Organization/United Nations University (WHO/FAO/UNU) 2007 safe levels of protein intake in at
least one age range. Precursor-free amino acids (PFAA) were prescribed by 40% of centres
(10/25) caring for 36% (29/80) of all the patients. For MMAB12nr patients, 72% of centres
(n=31/43) prescribed natural protein below the safe levels of protein intake (WHO/FAO/UNU
2007) in at least one age range. PFAA were prescribed by 77% of centres (n=33/43) managing
81% (n=174/215) of patients. In MMAB12nr patients, 90 (42%) required tube feeding: 25 via a
nasogastric tube and 65 via a gastrostomy.
Conclusions
A high percentage of centres used PFAA in MMA patients together with a protein prescription that
provided less than the safe levels of natural protein intake. However, there was inconsistent
practices across Europe. Long-term efficacy studies are needed to study patient outcome when
using PFAA with different severities of natural protein restrictions in patients with MMA to guide
future practice.
This article offers supplementary material which is provided at the end of the article.
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